A Study of Oral Vismodegib in Combination With Pirfenidone in Participants With Idiopathic Pulmonary Fibrosis
Public ClinicalTrials.gov record NCT02648048. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Single Arm, Multicenter, Open-label, Phase 1b Study to Assess the Safety and Tolerability of Oral Vismodegib in Combination With Pirfenidone in Patients With Idiopathic Pulmonary Fibrosis
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This is a single arm, multicenter, open-label, Phase 1b study to evaluate the safety and tolerability of vismodegib in combination with pirfenidone in participants with idiopathic pulmonary fibrosis (IPF) currently being treated with pirfenidone.
Study identification
- NCT ID
- NCT02648048
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 1
- Enrollment
- 21 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 40 Years to 80 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jan 15, 2016 (Actual)
- Primary completion
- Nov 30, 2016 (Actual)
- Completion
- Nov 30, 2016 (Actual)
- Last update posted
- Oct 30, 2017
2016
United States locations
- U.S. sites
- 14
- U.S. states
- 12
- U.S. cities
- 14
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Scripps Clinic | La Jolla | California | 92037 | — |
| Central Florida Pulmonary Group, PA | Orlando | Florida | 32803 | — |
| Suburban Lung Associates | Elk Grove | Illinois | 60007 | — |
| Medical Consultants, PC ; Pulmonary | Muncie | Indiana | 47303 | — |
| University of Louisville | Louisville | Kentucky | 40202-1798 | — |
| Tulane University Medical School | New Orleans | Louisiana | 70112 | — |
| Steward St. Elizabeth's Medical Center ; Pulmonary, Critical Care and Sleep Medicine | Boston | Massachusetts | 02135 | — |
| Creighton University Medical Center | Omaha | Nebraska | 68131 | — |
| Allied Clinical Research | Reno | Nevada | 89503 | — |
| Atlantic Respiratory Institute | Summit | New Jersey | 07901 | — |
| Pulmonix LLC | Greensboro | North Carolina | 27403 | — |
| PMG Research of Wilmington | Wilmington | North Carolina | 28401 | — |
| Western Washington Medical Group | Everett | Washington | 98208 | — |
| Swedish Medical Center | Seattle | Washington | 98122 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 1 non-U.S. site.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02648048, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Oct 30, 2017 · Synced Oct 18, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT02648048 live on ClinicalTrials.gov.